MariMed Inc (MRMD)
0.2516
0.00 (0.00%)
USD |
OTCM |
May 17, 15:59
MariMed Free Cash Flow: -5.117M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -5.117M |
| December 31, 2023 | -12.85M |
| September 30, 2023 | -11.39M |
| June 30, 2023 | -12.09M |
| March 31, 2023 | -17.75M |
| December 31, 2022 | -5.43M |
| September 30, 2022 | -0.413M |
| June 30, 2022 | 2.356M |
| March 31, 2022 | 17.65M |
| December 31, 2021 | 17.29M |
| September 30, 2021 | 14.16M |
| June 30, 2021 | 9.851M |
| March 31, 2021 | 4.046M |
| December 31, 2020 | -1.562M |
| September 30, 2020 | -5.806M |
| June 30, 2020 | -10.55M |
| March 31, 2020 | -28.15M |
| December 31, 2019 | -34.12M |
| September 30, 2019 | -34.11M |
| June 30, 2019 | -32.36M |
| March 31, 2019 | -17.43M |
| December 31, 2018 | -11.83M |
| September 30, 2018 | -19.14M |
| Date | Value |
|---|---|
| June 30, 2018 | -20.96M |
| March 31, 2018 | -19.71M |
| December 31, 2017 | -19.21M |
| September 30, 2017 | -8.811M |
| June 30, 2017 | -5.814M |
| March 31, 2017 | -3.998M |
| December 31, 2016 | -3.562M |
| September 30, 2016 | -4.167M |
| June 30, 2016 | -2.170M |
| March 31, 2016 | -3.444M |
| December 31, 2015 | -3.442M |
| September 30, 2015 | -3.226M |
| June 30, 2015 | -3.478M |
| March 31, 2015 | -0.2565M |
| December 31, 2014 | -0.4552M |
| September 30, 2014 | -0.1324M |
| June 30, 2014 | -0.1282M |
| March 31, 2014 | -0.047M |
| December 31, 2013 | -0.0107M |
| September 30, 2013 | 0.0129M |
| June 30, 2013 | -0.0388M |
| March 31, 2013 | -0.0984M |
| December 31, 2012 | -0.1275M |
Free Cash Flow Range, Past 5 Years
-34.12M
Minimum
Dec 2019
17.65M
Maximum
Mar 2022
-7.316M
Average
-5.618M
Median
Free Cash Flow Benchmarks
| Emergent BioSolutions Inc | -132.20M |
| Zymeworks Inc | -77.13M |
| Viemed Healthcare Inc | 8.473M |
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -33.83M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 3.21M |
| Cash from Investing (Quarterly) | -4.266M |
| Cash from Financing (Quarterly) | 1.645M |
| Free Cash Flow Per Share (Quarterly) | -0.0011 |
| Free Cash Flow to Equity (Quarterly) | -2.553M |
| Free Cash Flow to Firm (Quarterly) | -5.627M |
| Free Cash Flow Yield | -5.48% |